New research conducted by scientists at Oregon State University reveals that individuals who use cannabis frequently often begin their days with significantly higher levels of cortisol compared to non-users. Published in the peer-reviewed journal Cannabis, the study highlights a potentially profound connection between regular cannabis consumption and long-term alterations in the human body’s circadian stress-response mechanisms. While millions of people turn to cannabis for acute relief from anxiety and daily pressure, this investigation suggests that habitual use over time may fundamentally interfere with the biological systems tasked with regulating how the body anticipates and reacts to stress.
Led by Anita Cservenka, an associate professor in the Oregon State University College of Liberal Arts, alongside colleagues Julia Donner and Alexia Obrochta, the research provides a critical lens into the neuroendocrine impacts of modern cannabis habits. The study focuses specifically on the hypothalamic-pituitary-adrenal (HPA) axis, the intricate network of glands, hormones, and receptors responsible for governing the body’s reaction to stress, energy regulation, immune responses, and mood. As legal frameworks shift and cultural perceptions evolve across the United States, uncovering the physiological consequences of frequent cannabinoid intake has become an urgent priority for public health researchers.
Evolving Landscape of Cannabis Consumption Among Young Adults
The release of these findings coincides with a period of rapid transformation in American substance use patterns. Over the past fifteen years, national epidemiological data has demonstrated a dramatic surge in cannabis prevalence, particularly among young adults. According to recent public health metrics, approximately 29 percent of adults aged 19 to 30 report using cannabis within any given 30-day window, nearly doubling the usage rates recorded a decade and a half ago.
More critically, high-frequency usage—defined by public health surveys as using cannabis 20 or more times within a 30-day period—has escalated at an even faster pace. Today, more than 10 percent of young adults fall into this high-frequency category, a proportion that is more than double the figures observed fifteen years prior. This widespread normalization of daily or near-daily use has prompted scientists to examine how chronic exposure to phytocannabinoids alters fundamental neurobiological processes. Because stress remains one of the primary motivations individuals cite for initiating and maintaining cannabis use, understanding the bidirectional relationship between the drug and the body’s chemical messengers is vital for developing effective clinical guidance.
Deconstructing the Cortisol Awakening Response
To investigate how the HPA axis reacts to chronic cannabis exposure, the Oregon State University research team centered their investigation on the cortisol awakening response, commonly known as CAR. Cortisol, frequently referred to as the body’s primary "stress hormone," is a steroid hormone synthesized and secreted by the adrenal glands, which sit atop the kidneys. Under normal physiological conditions, cortisol production follows a predictable diurnal rhythm: levels are relatively low during the middle of the night, experience a sharp surge upon waking, peak roughly 30 minutes after an individual opens their eyes, and then steadily decline over the course of the day.
CAR is calculated by measuring the concentration of free cortisol in saliva immediately upon waking and comparing it to a second sample taken 30 minutes later. The mathematical difference between these two readings serves as a primary biological indicator of how effectively the neuroendocrine system is priming the body to manage the anticipated physical and mental demands of the upcoming day.
In their analysis, the OSU researchers observed that the magnitude of the CAR spike—the absolute change in cortisol from minute zero to minute 30—was remarkably similar between frequent cannabis users and non-users. However, a striking discrepancy emerged at the baseline starting point. Individuals who used cannabis frequently already exhibited significantly higher baseline concentrations of circulating cortisol the exact moment they woke up, effectively shifting their entire daily endocrine curve upward before their feet even touched the floor.
Navigating Contradictory Scientific Literature
The implications of this baseline elevation introduce new complexity to an already nuanced field of study. Prior research teams examining the intersection of cannabis and endocrine function have occasionally reported contrasting outcomes. Some historical studies observed a "blunted" CAR in habitual cannabis consumers, characterized by a dampened or flattened cortisol surge in the morning. Cservenka and her colleagues note that their failure to replicate those specific blunted responses underscores the intricate nature of human neuroendocrinology.
Discrepancies across academic literature often stem from methodological differences, including variations in participant age, sample sizes, frequency definitions, toxicological verification of cannabis potency, and the specific statistical strategies employed by researchers. Cservenka emphasizes that while the Oregon State University study establishes a clear association between frequent use and elevated morning cortisol, it does not definitively prove causation.
"We would need to study the same groups of people over a longer period of time to understand any cause-and-effect relationship, but we think this provides an important starting point," Cservenka noted. Longitudinal research tracking individuals as they either initiate, maintain, or cease cannabis consumption will be required to determine whether elevated morning cortisol is a direct neurological consequence of long-term cannabinoid exposure or if pre-existing endocrine profiles predispose certain individuals toward frequent usage.
The Physiological Role of Cortisol and Health Implications
To fully comprehend why elevated morning cortisol matters, it is necessary to examine the multifaceted roles cortisol plays within human physiology. Beyond its colloquial title as a stress hormone, cortisol is indispensable for survival. It acts as a master chemical messenger that influences metabolism, regulates blood pressure, controls inflammation, supports immune function, and assists in blood sugar homeostasis.
In acute, short-term scenarios, a surge of cortisol is entirely healthy and adaptive. It mobilizes glucose stores to provide instant energy, sharpens cognitive focus, and dampens non-essential bodily functions like digestion to help an individual survive an immediate threat or high-pressure situation. Once the stressor passes, a healthy feedback loop signals the HPA axis to dial down production, allowing hormone levels to return to baseline.
However, when baseline cortisol remains chronically elevated—whether due to psychological trauma, chronic lifestyle stressors, or chemical alterations within the endocrine system—the consequences can become deleterious. Prolonged exposure to high cortisol levels has been reliably linked in medical literature to a cascade of adverse physical and mental health outcomes. These include heightened risks for clinical anxiety, major depressive disorder, sleep disturbances, cognitive impairment, compromised immune response, and long-term cardiovascular complications such as hypertension and atherosclerosis.
By demonstrating that frequent cannabis users begin their days with elevated cortisol, the OSU study raises important questions regarding whether chronic use might inadvertently lock the neuroendocrine system into a persistent state of hyper-arousal, counteracting the very relaxation or stress-relief benefits that users often seek from the substance.
Methodological Strengths and Funding Background
The research project was supported financially through institutional grants provided by Oregon State University, the OSU Center for the Humanities, and the OSU College of Liberal Arts. By focusing on a rigorously screened cohort of young adults, the research team was able to control for numerous confounding variables, though the investigators readily acknowledge the inherent limitations associated with cross-sectional observational designs.
The recruitment process prioritized capturing accurate reporting of consumption habits, acknowledging the wide variance in modern cannabis products, which now feature significantly higher concentrations of delta-9-tetrahydrocannabinol (THC) than those available in previous decades. As commercial products evolve to include potent concentrates, edibles, and oils, the chemical burden placed on the human endocannabinoid system has intensified, making modern findings particularly relevant to contemporary public health discussions.
Broader Impacts and Future Clinical Directions
As state-level legalization continues to sweep across the United States, public health agencies face the challenge of providing evidence-based education that separates anecdotal experiences from empirical physiological data. Many consumers utilize cannabis as an evening unwind mechanism or a sleep aid, unaware of the potential delayed systemic impacts on their morning neurochemistry.
Cservenka and her colleagues propose that assessing morning cortisol levels could eventually evolve into a valuable, non-invasive neurobiological marker for identifying problematic or high-risk cannabis consumption patterns before they manifest as severe clinical disorders. However, translating these findings into actionable medical guidelines will require expansive, longitudinal studies that follow diverse cohorts across multiple years.
Furthermore, these insights invite a deeper re-evaluation of how societal stressors, mental health struggles, and substance use intersect. If chronic cannabis use inadvertently disrupts the body’s natural daily stress rhythms, users may find themselves trapped in a complex feedback loop: a dysregulated stress response produces baseline discomfort or anxiety, which in turn drives further self-medication with cannabis, thereby perpetuating the endocrine alteration.
As the scientific community continues to untangle these physiological feedback loops, the Oregon State University study serves as a foundational step toward a more sophisticated, biologically grounded understanding of how cannabis interacts with the human body. For clinicians, policymakers, and consumers alike, the findings underscore the reality that even widely accepted methods of coping with stress can carry hidden biological footprints, necessitating careful consideration as societal patterns of consumption continue to expand.
